Dr. Hamza

Mounjaro, known generically as tirzepatide, helps many adults manage type 2 diabetes and support weight loss through once-weekly subcutaneous injections. The pen device delivers the … Read more

High blood pressure often accompanies excess weight and conditions like type 2 diabetes, raising risks for heart disease and stroke. Semaglutide, the active ingredient in … Read more

Tirzepatide, the active ingredient in Mounjaro and Zepbound, has transformed weight management and type 2 diabetes care for countless people. By activating both GLP-1 and … Read more

Zepbound (tirzepatide) offers one of the most powerful approved options for chronic weight management in adults with obesity or overweight plus at least one weight-related … Read more

Mounjaro (tirzepatide) often feels like a game-changer in the first few months. Appetite drops sharply, food noise quiets down, portions shrink naturally, and the scale … Read more

Mounjaro at 5 mg is the first “real” maintenance dose most people reach after the 2.5 mg starter phase. By this point the strong appetite … Read more

Mounjaro at 15 mg—the highest approved weekly dose—delivers some of the strongest appetite suppression and metabolic changes seen with any GLP-1/GIP medication. In clinical trials, … Read more

Mounjaro (tirzepatide) remains one of the most effective weekly injections available for adults with type 2 diabetes or chronic weight issues. The dual GLP-1/GIP action … Read more